Sunshine Biopharma, Inc — Form D
Sunshine Biopharma, Inc of MONTREAL, A8, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-17. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-05-17
- Form: D
- Accession: 0001683168-23-003492
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 1
- Date of first sale: 2023-05-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-481966
Issuer
- Name: Sunshine Biopharma, Inc
- CIK: 0001402328
- Entity type: Corporation
- Jurisdiction: COLORADO
- Address: 469 Jean-Talon West, MONTREAL, A8, H3N 1R4
- Phone: 514-764-9698
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Andrew N Keller | Director | Point-Claire, A8 |
| Rabi N Kiderach | Director | Point-Claire, A8 |
| Abderrazzak N Merzouki | Director | Point-Claire, A8 |
| David N Natan | Director | Point-Claire, A8 |
| Steve N Slilaty | Director | Point-Claire, A8 |
| Abderrazzak N Merzouki | Executive Officer | Point-Claire, A8 |
| Camille N Sebaaly | Executive Officer | Point-Claire, A8 |
| Steve N Slilaty | Executive Officer | Point-Claire, A8 |
| Rabi N Kiderchah | Director | POINTE-CLAIRE, A8 |
| Steve N. Slilaty | Director | Montreal, A8 |
| Steve N. Slilaty | Executive Officer | Montreal, A8 |
| Camille N. Sebaaly | Director | Montreal, A8 |
| Camille N. Sebaaly | Executive Officer | Montreal, A8 |
| Michele N. Di Turi | Director | Montreal, A8 |
| Michele N. Di Turi | Executive Officer | Montreal, A8 |
Other filings by this issuer (3)
More